Merzenich Elected to Institute o... (0scientists from prestigious universitie...)

(Date:1/8/2009)..., OAKLAND, Calif., Jan. 8 /PRNewswire-FirstCall/...WorldHeart") announced today that it has submitted...cation to the US Food and Drug Administration ("FD...lant ("BTT") study of the Levacor(TM) Ventricular ...n includes detailed device information, including ...

(Date:1/8/2009)..., Former American Health Information Community b...hieve nationwide electronic health information net... National eHealth Collaborative, formerly AHIC Suc...hington, D.C. The National eHealth Collaborative ...reation of a secure, interoperable, nationwide hea...

(Date:1/8/2009)...Researchers find it prolongs lives of key vision c...hDay News) -- Researchers working with mice have i...ves of retinal cells in both healthy and diseased ...atments that would prevent blindness among people ..., the scientists said. , The protein, known as ...

(Date:1/8/2009)..., WASHINGTON, Jan. 8 ...timony of U.S. Secretary-Designate of Health and H...Committee on Health, Education, Labor and Pensions...ion in the new Administration. Daschle testified ...izing a sick care system to a health care system, ...

Breaking Medicine News(10 mins):Health News:WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD 2 Health News:National eHealth Collaborative Launched 2 Health News:National eHealth Collaborative Launched 3 Health News:National eHealth Collaborative Launched 4 Health News:National eHealth Collaborative Launched 5 Health News:National eHealth Collaborative Launched 6 Health News:Protein Might One Day Prevent Blindness 2 Health News:Protein Might One Day Prevent Blindness 3 Health News:Trust for America's Health Applauds Daschle's Commitment to Prevention 2

[0] WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD [0] National eHealth Collaborative Launched [0] Protein Might One Day Prevent Blindness [0] Trust for America's Health Applauds Daschle's Commitment to Prevention

...ations program is headed by Dr. Valentin Fuster be...ovasculares Carlos III, (CNIC), and the Mount Sina...cular research across the world. //A commitment of...de by the CNIC to Mount Sinai. The CNIC seeks to...

... Madison School of Veterinary Medicine has develop... dogs. They have worked in collaboration with the.... This newly developed// anti-cancer vaccine is v... the animal, but not all dogs with melanoma respon...

...ransmission of hepatitis B can be prevented by imm...s B, according to a BMJ published study. The world...s of hepatitis B,// which is transmitted through b...f these infections are accounted for by mother to ...

...hed fact that any genetic alterations in either th...cer. The BRCA1 gene, has been known to play a sign...cells present in the breast. Researchers from Geor...hat the BRCA1 gene also controls the activity of a...

Other Medicine News:Health News:Scientists Unravel Link Between HRT And Breast Cancer Gene, BRCA1 2

CNIC To Provide Funds To Mount Sinai School Vaccines developed, to treat melanoma in dogs Infants Need to Be Vaccinated For Hepatitis B Scientists Unravel Link Between HRT And Breast Cancer Gene, BRCA1

(Date:1/3/2009)... , , ROSEMONT, Ill., Jan. 2 /PRNewswire-USNewsw...ing technology providing an increasing number of c...ck pain according to an article in the January 200...Orthopaedic Surgeons ( http://www.jaaos.org/ ). I...dditional technical developments will allow MRI to...

(Date:12/27/2008)..., Dec. 23 Warner Chilcot...ne of its subsidiaries and Mayne Pharma Internatio...Inc., have filed lawsuits against each of Mutual P...maceuticals Inc. ("Mylan") and Impax Laboratories,...trict of New Jersey for infringement of Mayne,s U....

(Date:12/17/2008)...t in development and validation of non-animal alte...c. 17 MatTek Corporation today ann...e (ESAC) endorsed the scientific validity of the M...November meeting. ESAC concluded that the Modifie...ity for the prediction of skin irritating and non-...

(Date:12/17/2008)...17 PEAK Surgical, Inc., a medical,...ssection system based on a,proprietary technology...inistration (FDA) has granted the company 510(k) c... cutting and coagulation of soft tissue during,pl...t), gynecologic,orthopedic, arthroscopic, spinal...

Breaking Medicine Technology:MRI Emerges As Vital Resource in Treatment of Back Pain 2 MRI Emerges As Vital Resource in Treatment of Back Pain 3 Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2 Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3 EpiDerm's Skin Irritation Test Fully Validated in European Union 2 PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2 PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3 PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4 AUDIO from Medialink and Pfizer 3A The 20th Annual American Diabetes Alert Day Reminds Us to Learn if We Are at Risk 15122 1 AUDIO from Medialink and Pfizer 3A The 20th Annual American Diabetes Alert Day Reminds Us to Learn if We Are at Risk 15122 2 MyMigraineConnection com and Migraine Expert Teri Robert Announce Seventh Annual Migraine and Headache Poetry Contest 15120 1 MyMigraineConnection com and Migraine Expert Teri Robert Announce Seventh Annual Migraine and Headache Poetry Contest 15120 2 MyMigraineConnection com and Migraine Expert Teri Robert Announce Seventh Annual Migraine and Headache Poetry Contest 15120 3 North American Insurance Leaders Inc Announces Results of the Annual Meeting of Stockholders 15115 1 International Eye Foundation Announces Partnership with Newport Creative Communications 15110 1 International Eye Foundation Announces Partnership with Newport Creative Communications 15110 2

[3] MRI Emerges As Vital Resource in Treatment of Back Pain [0] Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent [9] EpiDerm's Skin Irritation Test Fully Validated in European Union [3] PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications

...CELONA, Spain--(BUSINESS WIRE)--Apr 11, 2007 - New...revir (VX-950), one of,the most advanced investiga...of hepatitis C virus (HCV) infection, will be pres...ssociation for the,Study of the Liver (EASL) in Ba...d to telaprevir have been accepted for presentatio...

...hlights key data at the 42nd annual meeting of the...EASL), KENILWORTH, N.J., April 11, 2007 /PRNewswir...rms its commitment to advancing,the science and tr...on with several key data presentations at the Euro... 42nd annual meeting,in Barcelona, Spain, April 11...

Other Medicine Technology:Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 2 Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 3 Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 4 Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 5 Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 6 Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 2 Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 3 Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 4 Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 5 Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 6 Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 7

Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL)Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C

...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...

Medicine Products:

IgM, Serum IgG, Serum IgG, CSF Index IgG, CSF

Merzenich Elected to Institute o...(0scientists from prestigious universitie...),Health